Potential impact of the 2017 high blood pressure guideline beyond the United States: A case study of the People's Republic of China.

CONCLUSIONS: The 2017 ACC/AHA guideline brings potential for risk reduction in China and selectively recommends medication for those who would benefit most. Realizing such benefits would ultimately depend on the acceptance, adherence and feasibility of adopting this guideline.
PMID: 32521545 [PubMed - as supplied by publisher]

Source: American Journal of Hypertension - June 9, 2020 Category: Cardiology Authors: Barszczyk A, Yang D, Wei J, Huang W, Feng ZP, Lee K, Luo H Tags: Am J Hypertens Source Type: research